958
Views
42
CrossRef citations to date
0
Altmetric
Reviews

Angiotensin II type 2 receptor agonists: where should they be applied?

, &
Pages 501-513 | Published online: 21 Feb 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Maree T Smith & Arjun Muralidharan. (2015) Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain. Expert Opinion on Therapeutic Targets 19:1, pages 25-35.
Read now
Nelly Blaes & Jean-Pierre Girolami. (2013) Targeting the ‘Janus face' of the B2-bradykinin receptor. Expert Opinion on Therapeutic Targets 17:10, pages 1145-1166.
Read now
Ulrike Muscha Steckelings & Thomas Unger. (2012) Angiotensin II type 2 receptor agonists – where should they be applied?. Expert Opinion on Investigational Drugs 21:6, pages 763-766.
Read now

Articles from other publishers (39)

Yue An, Changyong Xu, Wenmin Liu, Ji Jiang, Pengfei Ye, Mei Yang, Weihua Zhu, Jingjing Yu, Manman Yu, Wuyi Sun, Jian Hong, Huan Qiu, Wei Wei & Shihao Zhang. (2024) Angiotensin II type-2 receptor attenuates liver fibrosis progression by suppressing IRE1α-XBP1 pathway. Cellular Signalling 113, pages 110935.
Crossref
Qian Wu, Naresh Kumar, William P. Lafuse, Omar Santiagonunez Ahumada, Noushin Saljoughian, Elizabeth Whetstone, Ashley Zani, Ashley K. Patton, Mona El Refaey, Amy Webb, Maciej Pietrzak, Lianbo Yu, Mahesh KC, Mark E. Peeples, Latha P. Ganesan, Jacob S. Yount & Murugesan V.S. Rajaram. (2022) Influenza A virus modulates ACE2 expression and SARS-CoV-2 infectivity in human cardiomyocytes. iScience 25:12, pages 105701.
Crossref
Junni Ma & Ruining Li. (2022) Research progress on the correlation between sacubitril-valsartan and cognitive function in hypertensive patients. Highlights in Science, Engineering and Technology 14, pages 107-114.
Crossref
Hui Lin, Frank Geurts, Luise Hassler, Daniel Batlle, Katrina M. Mirabito Colafella, Kate M. Denton, Jia L. Zhuo, Xiao C. Li, Nirupama Ramkumar, Masahiro Koizumi, Taiji Matsusaka, Akira Nishiyama, Martin J. Hoogduijn, Ewout J. Hoorn & A.H. Jan Danser. (2022) Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting. Pharmacological Reviews 74:3, pages 462-505.
Crossref
Takayuki Matsumoto, Josiane F. Silva & Rita C. Tostes. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 2543 2569 .
Takayuki Matsumoto, Josiane F. Silva & Rita C. Tostes. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions 1 28 .
Rodrigo Barbosa de Souza, Elisa Ito Kawahara, Luis Ernesto Farinha-Arcieri, Isabela Gerdes Gyuricza, Bianca Neofiti-Papi, Manuela Miranda-Rodrigues, Marilia Bianca Cruz Grecco Teixeira, Gustavo Ribeiro Fernandes, Renan Barbosa Lemes, Dieter P. Reinhardt, Cecília Helena Gouveia & Lygia V. Pereira. (2021) Hyperkyphosis is not dependent on bone mass and quality in the mouse model of Marfan syndrome. Bone 152, pages 116073.
Crossref
Edwyn O. Cruz-López, Estrellita Uijl & A. H. Jan Danser. (2021) Perivascular Adipose Tissue in Vascular Function: Does Locally Synthesized Angiotensinogen Play a Role?. Journal of Cardiovascular Pharmacology 78:6S, pages S53-S62.
Crossref
Daolai Zhang, Yanfei Wang, Hui Lin, Yujing Sun, Mingwei Wang, Yingli Jia, Xiao Yu, Hui Jiang, Wenming Xu, Jin‐Peng Sun & Zhigang Xu. (2020) Function and therapeutic potential of G protein‐coupled receptors in epididymis. British Journal of Pharmacology 177:24, pages 5489-5508.
Crossref
Dong Fan & Zamaneh Kassiri. (2020) Biology of Tissue Inhibitor of Metalloproteinase 3 (TIMP3), and Its Therapeutic Implications in Cardiovascular Pathology. Frontiers in Physiology 11.
Crossref
Yan Sun, Yang Li, Meili Wang, Mingming Yue, Lina Bai, Jingwei Bian, Weiwei Hao, Jing Sun, Suli Zhang & Huirong Liu. (2020) Increased AT2R expression is induced by AT1R autoantibody via two axes, Klf-5/IRF-1 and circErbB4/miR-29a-5p, to promote VSMC migration. Cell Death & Disease 11:6.
Crossref
Amalie Povlsen, Daniela Grimm, Markus Wehland, Manfred Infanger & Marcus Krüger. (2020) The Vasoactive Mas Receptor in Essential Hypertension. Journal of Clinical Medicine 9:1, pages 267.
Crossref
Laura Sabatino, Silvana Balzan, Claudia Kusmic & Giorgio Iervasi. (2018) Modification of gene expression profiling related to renin–angiotensin system in an ischemia/reperfusion rat model after T3 infusion. Molecular and Cellular Biochemistry 449:1-2, pages 277-283.
Crossref
Arthur D. Moes, David Severs, Koen Verdonk, Nils van der Lubbe, Robert Zietse, A. H. J. Danser & Ewout J. Hoorn. (2018) Mycophenolate Mofetil Attenuates DOCA-Salt Hypertension: Effects on Vascular Tone. Frontiers in Physiology 9.
Crossref
Peter Verbrugghe, Jelle Verhoeven, Marnick Clijsters, Dominique Vervoort, Jarne Schepens, Bart Meuris & Paul Herijgers. (2018) The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome. Journal of Cardiovascular Pharmacology 71:4, pages 215-222.
Crossref
Gian Paolo Rossi, Teresa M. Seccia, Matthias Barton, A.H. Jan Danser, Peter W. de Leeuw, Neeraj Dhaun, Damiano Rizzoni, Patrick Rossignol, Luis-Miguel Ruilope, Anton H. van den Meiracker, Sadayoshi Ito, Naoyuki Hasebe & David J. Webb. (2018) Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I. Journal of Hypertension 36:3, pages 451-461.
Crossref
Haiyan Wu, Bibi S. van Thiel, Paula K. Bautista-Niño, Erwin Reiling, Matej Durik, Frank P.J. Leijten, Yanto Ridwan, Renata M.C. Brandt, Harry van Steeg, Martijn E.T. Dollé, Wilbert P. Vermeij, Jan H.J. Hoeijmakers, Jeroen Essers, Ingrid van der Pluijm, A.H. Jan Danser & Anton J.M. Roks. (2017) Dietary restriction but not angiotensin II type 1 receptor blockade improves DNA damage-related vasodilator dysfunction in rapidly aging Ercc1Δ/− mice . Clinical Science 131:15, pages 1941-1953.
Crossref
Leonardo Puppulin, Giuseppe Pezzotti, Hongxin Sun, Shigekuni Hosogi, Takashi Nakahari, Toshio Inui, Yasuaki Kumamoto, Hideo Tanaka & Yoshinori Marunaka. (2017) Raman micro-spectroscopy as a viable tool to monitor and estimate the ionic transport in epithelial cells. Scientific Reports 7:1.
Crossref
Bingbing Pan, Zhigang Cheng, Gaoyin Kong, Zongbin Song, Yunjiao Wang, Lai Wei, Dan Xiao, Yuan Zhao & Qulian Guo. (2017) Propofol inhibits expression of angiotensin II receptor type 2 in dorsal root ganglion neurons. Experimental and Therapeutic Medicine 13:3, pages 867-872.
Crossref
Jay S Mishra, Gary D Hankins & Sathish Kumar. (2016) Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta. Journal of the Renin-Angiotensin-Aldosterone System 17:4, pages 147032031667487.
Crossref
Bibi S. van Thiel, Ingrid van der Pluijm, Luuk te Riet, Jeroen Essers & A.H. Jan Danser. (2015) The renin–angiotensin system and its involvement in vascular disease. European Journal of Pharmacology 763, pages 3-14.
Crossref
Bruno Sevá PessôaDenise E. SlumpKhatera IbrahimiAldo GrefhorstRichard van VeghelIngrid M. GarreldsAnton J.M. RoksSteven A. KushnerA.H. Jan DanserJoep H.M. van Esch. (2015) Angiotensin II Type 2 Receptor– and Acetylcholine-Mediated Relaxation. Hypertension 66:2, pages 396-402.
Crossref
Koen VerdonkLangeza SalehStephanie LankhorstJ.E. Ilse SmildeManon M. van IngenIngrid M. GarreldsEdith C.H. FriesemaHenk RusscherAnton H. van den MeirackerWilly VisserA.H. Jan Danser. (2015) Association Studies Suggest a Key Role for Endothelin-1 in the Pathogenesis of Preeclampsia and the Accompanying Renin–Angiotensin–Aldosterone System Suppression. Hypertension 65:6, pages 1316-1323.
Crossref
Luuk te RietJoep H.M. van EschAnton J.M. RoksAnton H. van den MeirackerA.H. Jan Danser. (2015) Hypertension. Circulation Research 116:6, pages 960-975.
Crossref
Samuel Leblanc, Marie-Claude Battista, Christophe Noll, Anders HallbergNicole Gallo-Payet, André C. Carpentier, Donna F. Vine & Jean-Patrice Baillargeon. (2014) Angiotensin II Type 2 Receptor Stimulation Improves Fatty Acid Ovarian Uptake and Hyperandrogenemia in an Obese Rat Model of Polycystic Ovary Syndrome. Endocrinology 155:9, pages 3684-3693.
Crossref
Gerry T. M. WagenaarRozemarijn M. A. SengersEl Houari LaghmaniXueyu ChenMelissa P. H. A. LindeboomAnton J. M. RoksGert Folkerts & Frans J. Walther. (2014) Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats. American Journal of Physiology-Lung Cellular and Molecular Physiology 307:3, pages L261-L272.
Crossref
A.H. Jan Danser & Praveen Anand. (2014) The Angiotensin II Type 2 Receptor for Pain Control. Cell 157:7, pages 1504-1506.
Crossref
Ying Li, Xiao-Hui Li, Zhi-Jun Huang, Xiao-Hong Tang, Jing-Jing Liu & Hong Yuan. (2014) Metoprolol Restores Expression and Vasodilatation Function of AT2R in Spontaneously Hypertensive Rats. Journal of Cardiovascular Pharmacology 63:3, pages 252-258.
Crossref
Jean-Baptiste Veron, Advait Joshi, Charlotta Wallinder, Mats Larhed & Luke R. Odell. (2014) Synthesis and evaluation of isoleucine derived angiotensin II AT2 receptor ligands. Bioorganic & Medicinal Chemistry Letters 24:2, pages 476-479.
Crossref
Gerry T. M. WagenaarEl Houari LaghmaniMelissa FidderRozemarijn M. A. SengersYvonne P. de VisserLouwe de VriesRick RinkAnton J. M. RoksGert Folkerts & Frans J. Walther. (2013) Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology 305:5, pages L341-L351.
Crossref
Roman Hafko, Sonia Villapol, Regina Nostramo, Aviva Symes, Esther L. Sabban, Tadashi Inagami & Juan M. Saavedra. (2013) Commercially Available Angiotensin II At2 Receptor Antibodies Are Nonspecific. PLoS ONE 8:7, pages e69234.
Crossref
Marie‐Odile Guimond, Marie‐Claude Battista, Fatemeh Nikjouitavabi, Maude Carmel, Véronique Barres, Alexandre A. Doueik, Ladan Fazli, Martin Gleave, Robert Sabbagh & Nicole Gallo‐Payet. (2013) Expression and role of the angiotensin II AT2 receptor in human prostate tissue: In search of a new therapeutic option for prostate cancer. The Prostate 73:10, pages 1057-1068.
Crossref
Claudia A. McCarthy, Robert E. Widdop, Kate M. Denton & Emma S. Jones. (2012) Update on the Angiotensin AT2 Receptor. Current Hypertension Reports 15:1, pages 25-30.
Crossref
Michaël ShumSandra PinardMarie-Odile GuimondSébastien M. LabbéClaude RobergeJean-Patrice BaillargeonMarie-France LangloisMathias Alterman, Charlotta Wallinder, Anders Hallberg, André C. CarpentierNicole Gallo-Payet. (2013) Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats. American Journal of Physiology-Endocrinology and Metabolism 304:2, pages E197-E210.
Crossref
Bruno Sevá Pessôa, Nils van der Lubbe, Koen Verdonk, Anton J. M. Roks, Ewout J. Hoorn & A. H. Jan Danser. (2012) Key developments in renin–angiotensin–aldosterone system inhibition. Nature Reviews Nephrology 9:1, pages 26-36.
Crossref
Marie-Odile Guimond, Charlotta Wallinder, Mathias Alterman, Anders Hallberg & Nicole Gallo-Payet. (2013) Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT2) receptor. Effects on neurite outgrowth in NG108-15 cells. European Journal of Pharmacology 699:1-3, pages 160-171.
Crossref
Koen VerdonkMatej DurikNalina Abd-AllaWendy W. BatenburgAntoon J. van den BogaerdtRichard van VeghelAnton J.M. RoksA.H. Jan DanserJoep H.M. van Esch. (2012) Compound 21 Induces Vasorelaxation via an Endothelium- and Angiotensin II Type 2 Receptor-Independent Mechanism. Hypertension 60:3, pages 722-729.
Crossref
Marie-Odile Guimond & Nicole Gallo-Payet. (2012) The Angiotensin II Type 2 Receptor in Brain Functions: An Update. International Journal of Hypertension 2012, pages 1-18.
Crossref
Qian Wu, William Lafuse, Naresh Kumar, Noushin Saljoughian, Ashley Zian, Ashley Patton, Latha P. Ganesan, Jacob Yount & Murugesan V.S Rajaram. (2021) Influenza A Virus Modulates ACE2 Expression and SARS-CoV-2 Infectivity in Human Cardiomyocytes. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.